Complication rate across the minimally invasive surgical treatments (MISTs): where do we stand? A systematic review of the literature (2024)

References

  1. Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019;10:ED000142.

  2. McVary KT. BPH: epidemiology and comorbidities. Am J Managed Care. 2006;12:S122–8.

    Google Scholar

  3. Anezaki H, Endo F, Swan G, Takashima K, Rojanasarot S. Cost-effectiveness analysis of minimally invasive surgical treatments for benign prostatic hyperplasia: implications for Japan’s public healthcare system. J Med Econ. 2024;27:554–65.

    Article PubMed Google Scholar

  4. Sun Y, Peng B, Lei GL, Wei Q, Yang L. Study of phosphodiesterase 5 inhibitors and α-adrenoceptor antagonists used alone or in combination for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Ital J Urol Nephrol. 2020;72:13–21.

    Google Scholar

  5. Zhang Y, Yuan P, Ma D, Gao X, Wei C, Liu Z, et al. Efficacy and safety of enucleation vs. resection of prostate for treatment of benign prostatic hyperplasia: a meta-analysis of randomized controlled trials. Prostate Cancer Prostatic Dis. 2019;22:493–508.

    Article CAS PubMed Google Scholar

  6. Cornu JN, Dupuis H, Gazdovich S. Hot Topics of the Past Decade: Evolutions and Revolutions in Lower Urinary Tract Symptoms. Eur Urol Focus. 2022;8:371–4.

    Article PubMed Google Scholar

  7. Huang SW, Tsai CY, Tseng CS, Shih MC, Yeh YC, Chien KL, et al. Comparative efficacy and safety of new surgical treatments for benign prostatic hyperplasia: systematic review and network meta-analysis. BMJ. 2019;367:l5919.

    Article PubMed PubMed Central Google Scholar

  8. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8:336–41.

    Article PubMed Google Scholar

  9. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.

    Article PubMed PubMed Central Google Scholar

  10. Bhojani N, Bidair M, Zorn KC, Trainer A, Arther A, Kramolowsky E, et al. Aquablation for Benign Prostatic Hyperplasia in Large Prostates (80-150 cc): 1-Year Results. Urology 2019;129:1–7.

    Article PubMed Google Scholar

  11. Gilling P, Barber N, Bidair M, Anderson P, Sutton M, Aho T, et al. Three-year outcomes after Aquablation therapy compared to TURP: results from a blinded randomized trial. Can J Urol. 2020;27:10072–9.

    PubMed Google Scholar

  12. De Nunzio C, Cantiello F, Fiori C, Crocerossa F, Tognoni P, Amparore D, et al. Urinary and sexual function after treatment with temporary implantable nitinol device (iTind) in men with LUTS: 6-month interim results of the MT-06-study. World J Urol. 2021;39:2037–42.

    Article PubMed Google Scholar

  13. Elterman D, Shepherd S, Saadat SH, Alshak MN, Bhojani N, Zorn KC, et al. Prostatic urethral lift (UroLift) versus convective water vapor ablation (Rezum) for minimally invasive treatment of BPH: a comparison of improvements and durability in 3-year clinical outcomes. Can J Urol. 2021;28:10824–33.

    PubMed Google Scholar

  14. Sønksen J, Barber NJ, Speakman MJ, Berges R, Wetterauer U, Greene D, et al. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study. Eur Urol. 2015;68:643–52.

    Article PubMed Google Scholar

  15. Samir M, Elaal AAA, Gad KAS, Basyony MW. Two-year follow-up comparing Rezūm therapy versus bipolar transurethral resection of the prostate for treating benign prostatic hyperplasia. A prospective randomized study. Int J Urol. 2024;31:545–50.

  16. Roehrborn CG, Gange SN, Gittelman MC, Goldberg KA, Patel K, Shore ND, et al. Convective Thermal Therapy: Durable 2-Year Results of Randomized Controlled and Prospective Crossover Studies for Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia. The. J Urol. 2017;197:1507–16.

    Article PubMed Google Scholar

  17. Bertolo R, Ditonno F, Veccia A, De Marco V, Migliorini F, Porcaro AB, et al. Postoperative outcomes of transperitoneal versus retroperitoneal robotic partial nephrectomy: a propensity-score matched comparison focused on patient mobilization, return to bowel function, and pain. J Robotic Surg. 2024;18:96.

    Article Google Scholar

  18. Canat HL, Gurbuz C, Bozkurt M. Transurethral resection of the prostate (TURP) versus transperineal laser ablation (TPLA) due to benign prostatic hyperplasia (BPH): prospective and comparative study. Int Urol Nephrol. 2023;55:2747–52.

    Article CAS PubMed Google Scholar

  19. Gilling PJ, Barber N, Bidair M, Anderson P, Sutton M, Aho T, et al. Randomized Controlled Trial of Aquablation versus Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia: One-year Outcomes. Urology 2019;125:169–73.

    Article PubMed Google Scholar

  20. Labban M, Mansour M, Abdallah N, Jaafar R, Wazzan W, Bulbul M, et al. Aquablation for benign prostatic obstruction: Single center technique evolution and experience. Investigative Clin Urol. 2021;62:210–6.

    Article Google Scholar

  21. Desai M, Bidair M, Bhojani N, Trainer A, Arther A, Kramolowsky E, et al. WATER II (80-150 mL) procedural outcomes. BJU Int. 2019;123:106–12.

    Article PubMed Google Scholar

  22. Misrai V, Rijo E, Zorn KC, Barry-Delongchamps N, Descazeaud A. Waterjet Ablation Therapy for Treating Benign Prostatic Obstruction in Patients with Small- to Medium-size Glands: 12-month Results of the First French Aquablation Clinical Registry. Eur Urol. 2019;76:667–75.

    Article PubMed Google Scholar

  23. Zorn KC, Bidair M, Trainer A, Arther A, Kramolowsky E, Desai M, et al. Aquablation therapy in large prostates (80-150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3-year trial results. BJUI Compass. 2022;3:130–8.

    Article PubMed Google Scholar

  24. Bach T, Gilling P, El Hajj A, Anderson P, Barber N. First Multi-Center All-Comers Study for the Aquablation Procedure. J Clin Med. 2020;9:603.

  25. Desai M, Bidair M, Bhojani N, Trainer A, Arther A, Kramolowsky E, et al. Aquablation for benign prostatic hyperplasia in large prostates (80-150 cc): 2-year results. Can J Urol. 2020;27:10147–53.

    PubMed Google Scholar

  26. Rukstalis D, Grier D, Stroup SP, Tutrone R, deSouza E, Freedman S, et al. Prostatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift Study. Prostate Cancer Prostatic Dis. 2019;22:411–9.

    Article PubMed Google Scholar

  27. de Rienzo G, Lorusso A, Minafra P, Zingarelli M, Papapicco G, Lucarelli G, et al. Transperineal interstitial laser ablation of the prostate, a novel option for minimally invasive treatment of benign prostatic obstruction. Eur Urol. 2021;80:95–103.

    Article PubMed Google Scholar

  28. Cai HJ, Fang JH, Kong FL, Xu CK, Chen CH, Wang W, et al. Ultrasound-guided transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a new minimally invasive interventional therapy. Acta Radiol. 2022;63:553–8.

    Article PubMed Google Scholar

  29. Frego N, Saita A, Casale P, Diana P, Contieri R, Avolio PP, et al. Feasibility, safety, and efficacy of ultrasound-guided transperineal laser ablation for the treatment of benign prostatic hyperplasia: a single institutional experience. World J Urol. 2021;39:3867–73.

    Article PubMed Google Scholar

  30. Ghiraldi E, Higgins AM, Sterious S. Initial Experience Performing “Cautery-Free Waterjet Ablation of the Prostate”. J Endourol. 2022;36:1237–42.

    Article PubMed Google Scholar

  31. El-Asmar JM, Labban M, El-Hajj A. Integration of aquablation through telemetry: an alternative to onsite proctoring? World J Urol. 2021;39:3473–9.

    Article PubMed PubMed Central Google Scholar

  32. Elterman DS, Foller S, Ubrig B, Kugler A, Misrai V, Porreca A, et al. Focal bladder neck cautery associated with low rate of post-Aquablation bleeding. Can J Urol. 2021;28:10610–3.

    PubMed Google Scholar

  33. McVary KT, Roehrborn CG. Three-Year Outcomes of the Prospective, Randomized Controlled Rezūm System Study: Convective Radiofrequency Thermal Therapy for Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia. Urology. 2018;111:1–9.

    Article PubMed Google Scholar

  34. Polverino P, Lo Re M, Saladino M, Pecoraro A, Moscardi L, Rivetti A, et al. Could transperineal interstitial laser ablation of the prostate be the right option for highly-comorbid patients with lower urinary tract symptoms due to benign prostatic obstruction? A preliminary single-center experience focusing on functional and safety outcomes. Minerva Urol Nephrol. 2024;76:646–9.

  35. Pacella CM, Patelli G, Iapicca G, Manenti G, Perretta T, Ryan CP, et al. Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study. Results at 6 and 12 months from a retrospective multi-centric study. Prostate Cancer Prostatic Dis. 2020;23:356–63.

    Article CAS PubMed Google Scholar

  36. Minore A, Morselli S, Franzoso F, Maruzzi D, Varvello F, Toso S, et al. Is water vapor thermal therapy safe and feasible in elderly and frail men? The Italian experience. World J Urol. 2024;42:60 https://doi.org/10.1007/s00345-023-04762-9

    Article PubMed Google Scholar

  37. Amparore D, Fiori C, Valerio M, Schulman C, Giannakis I, De Cillis S, et al. 3-Year results following treatment with the second generation of the temporary implantable nitinol device in men with LUTS secondary to benign prostatic obstruction. Prostate Cancer Prostatic Dis. 2021;24:349–57.

    Article CAS PubMed Google Scholar

  38. Sahakyan Y, Erman A, Bhojani N, Chughtai B, Zorn KC, Sander B, et al. Pharmacotherapy vs. minimally invasive therapies as initial therapy for moderate-to-severe benign prostatic hyperplasia: a cost-effectiveness study. Prostate Cancer Prostatic Dis. 2023;26:113–8.

    Article PubMed Google Scholar

  39. Tanneru K, Jazayeri SB, Alam MU, Kumar J, Bazargani S, Kuntz G, et al. An Indirect Comparison of Newer Minimally Invasive Treatments for Benign Prostatic Hyperplasia: A Network Meta-Analysis Model. J Endourol. 2021;35:409–16.

    Article PubMed Google Scholar

  40. Sibona M, Destefanis P, Vercelli E, Secco S, Gontero P, Cindolo L. Ejaculation physiology and dysfunction after BPH surgery: the role of the new MISTs. Prostate Cancer Prostatic Dis. 2023;26:475–82.

    Article PubMed Google Scholar

  41. Franco JV, Jung JH, Imamura M, Borofsky M, Omar MI, Escobar Liquitay CM, et al. Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis. Cochrane Database Syst Rev. 2021;7:CD013656.

    PubMed Google Scholar

  42. Porto JG, Arbelaez MCS, Blachman-Braun R, Bhatia A, Bhatia S, Satyanarayana R, et al. Complications associated with minimally invasive surgical therapies (MIST) for surgical management of benign prostatic hyperplasia: a Manufacturer and User Facility Device Experience (MAUDE) database review. World J Urol. 2023;41:1975–82.

    Article PubMed Google Scholar

  43. Zhu M, Babar M, Hawks-Ladds N, Tawfik MM, Loloi J, Labagnara K, et al. Real-world four-year functional and surgical outcomes of Rezum therapy in younger versus elderly men. Prostate Cancer Prostatic Dis. 2024;27:109–15.

    Article PubMed Google Scholar

  44. Bertolo R, Iacovelli V, Cipriani C, Carilli M, Vittori M, Antonucci M, et al. Ejaculatory function following transperineal laser ablation vs TURP for benign prostatic obstruction: a randomized trial. BJU Int. 2023;132:100–8.

    Article PubMed Google Scholar

  45. Kim J, Polchert M, Chacko B, Tannenbaum J, Raheem O. Do Minimally Invasive Benign Prostatic Hyperplasia Treatments Preserve Sexual Function? A Contemporary Review of the Literature. Curr Urol Rep. 2021;22:56.

    Article PubMed Google Scholar

  46. Elterman D, Gao B, Lu S, Bhojani N, Zorn KC, Chughtai B. New Technologies for Treatment of Benign Prostatic Hyperplasia. The. Urologic Clin North Am. 2022;49:11–22.

    Article Google Scholar

  47. Sun F, Yao H, Bao X, Wang X, Wang D, Zhang D, et al. The Efficacy and Safety of HoLEP for Benign Prostatic Hyperplasia With Large Volume: A Systematic Review and Meta-Analysis. Am J Mens Health. 2022;16:15579883221113204.

    Article Google Scholar

  48. Nguyen DD, Li T, Ferreira R, Baker Berjaoui M, Nguyen ALV, Chughtai B, et al. Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation. Prostate Cancer Prostatic Dis. 2024;27:22–8.

    Article PubMed Google Scholar

  49. Siena G, Sessa F, Cindolo L. Use of a Schelin Catheter for analgesia during Rezum treatment of the prostate. Prostate Cancer Prostatic Dis. 2024;27:147–9.

    Article CAS PubMed Google Scholar

  50. Roehrborn CG, Chin PT, Woo HH. The UroLift implant: mechanism behind rapid and durable relief from prostatic obstruction. Prostate Cancer Prostatic Dis. 2022;25:79–85.

    Article PubMed Google Scholar

  51. Tafuri A, Panunzio A, De Carlo F, Luperto E, Di Cosmo F, Cavaliere A, et al. Transperineal Laser Ablation for Benign Prostatic Enlargement: A Systematic Review and Pooled Analysis of Pilot Studies. J Clin Med. 2023;12:1860.

  52. Destefanis P, Sibona M, Vitiello F, Vercelli E, Micai L, Montefusco G, et al. Trans - Perineal laser ablation of the prostate in high surgical risk patients affected by severe lower urinary tract symptoms related to benign prostatic obstruction. Prostate Cancer Prostatic Dis. 2023 https://doi.org/10.1038/s41391-023-00736-5 Epub ahead of print.

Download references

Complication rate across the minimally invasive surgical treatments (MISTs): where do we stand? A systematic review of the literature (2024)

References

Top Articles
Latest Posts
Recommended Articles
Article information

Author: Prof. Nancy Dach

Last Updated:

Views: 5703

Rating: 4.7 / 5 (77 voted)

Reviews: 92% of readers found this page helpful

Author information

Name: Prof. Nancy Dach

Birthday: 1993-08-23

Address: 569 Waelchi Ports, South Blainebury, LA 11589

Phone: +9958996486049

Job: Sales Manager

Hobby: Web surfing, Scuba diving, Mountaineering, Writing, Sailing, Dance, Blacksmithing

Introduction: My name is Prof. Nancy Dach, I am a lively, joyous, courageous, lovely, tender, charming, open person who loves writing and wants to share my knowledge and understanding with you.